7-107786844-AACC-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PM4_SupportingPP5_Very_Strong
The NM_000111.3(SLC26A3):c.951_953delGGT(p.Val318del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000204 in 1,613,956 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: 𝑓 0.00037 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00019 ( 0 hom. )
Consequence
SLC26A3
NM_000111.3 disruptive_inframe_deletion
NM_000111.3 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.48
Genes affected
SLC26A3 (HGNC:3018): (solute carrier family 26 member 3) The protein encoded by this gene is a transmembrane glycoprotein that transports chloride ions across the cell membrane in exchange for bicarbonate ions. It is localized to the mucosa of the lower intestinal tract, particularly to the apical membrane of columnar epithelium and some goblet cells. The protein is essential for intestinal chloride absorption, and mutations in this gene have been associated with congenital chloride diarrhea. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_000111.3. Strenght limited to Supporting due to length of the change: 1aa.
PP5
Variant 7-107786844-AACC-A is Pathogenic according to our data. Variant chr7-107786844-AACC-A is described in ClinVar as [Pathogenic]. Clinvar id is 16754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-107786844-AACC-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC26A3 | NM_000111.3 | c.951_953delGGT | p.Val318del | disruptive_inframe_deletion | 8/21 | ENST00000340010.10 | NP_000102.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC26A3 | ENST00000340010.10 | c.951_953delGGT | p.Val318del | disruptive_inframe_deletion | 8/21 | 1 | NM_000111.3 | ENSP00000345873.5 | ||
SLC26A3 | ENST00000379083.7 | n.*742_*744delGGT | non_coding_transcript_exon_variant | 8/20 | 2 | ENSP00000368375.3 | ||||
SLC26A3 | ENST00000468551.1 | n.229_231delGGT | non_coding_transcript_exon_variant | 2/5 | 2 | |||||
SLC26A3 | ENST00000379083.7 | n.*742_*744delGGT | 3_prime_UTR_variant | 8/20 | 2 | ENSP00000368375.3 |
Frequencies
GnomAD3 genomes AF: 0.000375 AC: 57AN: 152174Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
57
AN:
152174
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000473 AC: 119AN: 251340Hom.: 0 AF XY: 0.000427 AC XY: 58AN XY: 135850
GnomAD3 exomes
AF:
AC:
119
AN:
251340
Hom.:
AF XY:
AC XY:
58
AN XY:
135850
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000187 AC: 273AN: 1461664Hom.: 0 AF XY: 0.000166 AC XY: 121AN XY: 727158
GnomAD4 exome
AF:
AC:
273
AN:
1461664
Hom.:
AF XY:
AC XY:
121
AN XY:
727158
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000374 AC: 57AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.000524 AC XY: 39AN XY: 74484
GnomAD4 genome
AF:
AC:
57
AN:
152292
Hom.:
Cov.:
32
AF XY:
AC XY:
39
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Congenital secretory diarrhea, chloride type Pathogenic:5
Pathogenic, no assertion criteria provided | literature only | Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM) | - | - - |
Pathogenic, no assertion criteria provided | curation | Reproductive Health Research and Development, BGI Genomics | Jan 06, 2020 | NM_000111.2:c.951_953delGGT in the SLC26A3 gene has an allele frequency of 0.005 in European (Finnish) subpopulation in the gnomAD database. The SLC26A3 c.951_953delGGT (p.Val318del) variant has been reported as a Finnish founder mutation, which has been detected in 45 patients (PMID: 21394828). The mouse p.V318del-homologue mutant (p.V310del) is retained in the endoplasmic reticulum, failing to show any expression on the apical plasma membrane (PMID: 21394828). Taken together, we interprete this variant as Pathogenic/Likely pathogenic. ACMG/AMP Criteria applied: PS4; PM4; PS3. - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 29, 2024 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 1996 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 24, 2024 | Variant summary: SLC26A3 c.951_953delGGT (p.Val318del) results in an in-frame deletion that is predicted to remove 1 amino acid from the encoded protein. The variant allele was found at a frequency of 0.00047 in 251340 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in SLC26A3 causing Congenital secretory diarrhea, chloride type, allowing no conclusion about variant significance. c.951_953delGGT has been reported in the literature in multiple individuals affected with Congenital secretory diarrhea (example, Hoglund_1996). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in 30%-50% of normal transporter activity in Xenopus Oocytes (Moseley_1999). The following publications have been ascertained in the context of this evaluation (PMID: 8896562, 9886994). ClinVar contains an entry for this variant (Variation ID: 16754). Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 16, 2023 | This variant has been observed in individual(s) with congenital secretory chloride diarrhea (PMID: 8896562, 21394828). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs386833491, gnomAD 0.5%), and has an allele count higher than expected for a pathogenic variant. This variant, c.951_953del, results in the deletion of 1 amino acid(s) of the SLC26A3 protein (p.Val318del), but otherwise preserves the integrity of the reading frame. ClinVar contains an entry for this variant (Variation ID: 16754). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects SLC26A3 function (PMID: 9886994). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at